Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

MSI Solid Tumors Refractory to PD1/PDL1 Antibody Monotherapy

Tundra lists 1 MSI Solid Tumors Refractory to PD1/PDL1 Antibody Monotherapy clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06549907

A Biomarker Exploratory Study of Dual Blockade of PD1/PDL1 and CTLA4 and Anti-angiogenic Therapy

This study is a single-center prospective exploratory research, aiming to identify clinical characteristics and biomarkers associated with the therapeutic effects of dual PD1/PDL1 and CTLA4 blockade plus anti-angiogenic therapy and investigate MR image characteristics during treatment in patients with MSS metastatic colorectal cancer and MSI solid tumors resistant to PD-1/PD-L1 antibody monotherapy.

Gender: All

Ages: 18 Years - Any

Updated: 2024-08-12

1 state

MSS Metastatic Colorectal Cancers

MSI Solid Tumors Refractory to PD1/PDL1 Antibody Monotherapy